THE DOSE OF ICS IN TRIPLE ICS/LABA/LAMA FDC MODULATES INFLAMMATION IN A HUMAN EX VIVO MODEL OF SEVERE EOSINOPHILIC ASTHMA

被引：0
|
作者：
Rogliani, Paola
Ora, Josuel
Motta, Enrico
Laitano, Rossella
Calzetta, Luigino
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.3186
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：4918A / 4918A
页数：1
相关论文
共 32 条
  • [1] Modulating the Level of ICS in Triple ICS/LABA/LAMA FDC: Effect Against Inflammation in a Human Ex Vivo Model of Severe Eosinophilic Asthma
    Rogliani, P.
    Ora, J.
    Motta, E.
    Melis, E.
    Facciolo, F.
    Calzetta, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [2] Modulating the Level of ICS in Triple ICS/LABA/LAMA FDC: Effect Against Airway Hyperresponsiveness in a Human Ex Vivo Model of Severe Eosinophilic Asthma
    Rogliani, P.
    Ora, J.
    Frugoni, C.
    Melis, E.
    Facciolo, F.
    Calzetta, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [3] The level of ICS in BDP/FF/GB modulates inflammation in a human ex vivo model of severe eosinophilic asthma
    Rogliani, Paola
    Ora, Josuel
    Motta, Enrico
    Melis, Enrico
    Facciolo, Francesco
    Calzetta, Luigino
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [4] Safety profile of triple ICS/LABA/LAMA FDC in the treatment of asthma: a meta-analysis
    Calzetta, L.
    Cavalli, F.
    Chetta, A.
    Cazzola, M.
    Rogliani, P.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [5] Efficacy and Safety of High ICS Dose Fixed-Combination ICS/LABA/LAMA pMDI Compared with ICS/LABA and ICS/LABA plus LAMA in Patients with Uncontrolled Asthma: The TRIGGER Study
    Canonica, G. W.
    Virchow, J.
    Kots, M.
    Zuccaro, F.
    Carzana, E.
    Vele, A.
    Georges, G.
    Petruzzelli, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [6] Predictors of treatment response to high-dose ICS/LABA or medium-dose ICS/LABA plus LAMA in asthma patients - TAILOR study
    Verhamme, K. M.
    De Ridder, M.
    Rijnbeek, P.
    Mosseveld, M.
    Pedersen, L.
    Marconi, E.
    Lapi, F.
    Tan, C.
    Delmestri, A.
    Prieto-Alhambra, D.
    Nudo, E.
    Brusselle, G.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [7] Triple (ICS/LABA/LAMA) vs. Dual (ICS/LABA) Therapy for Persistent, Uncontrolled Asthma: A Systematic Review and Meta-Analysis
    Kim, L.
    Saleh, C.
    Whalen-Browne, A.
    O'Byrne, P.
    Chu, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [8] Effect of ICS/LABA combination in an ex vivo model of COPD exacerbation
    Calzetta, Luigino
    Ritondo, Beatrice Ludovica
    Puxeddu, Ermanno
    Matera, Maria Gabriella
    Rogliani, Paola
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [9] TRIPLE THERAPY (ICS/LABA/LAMA) IN PATIENTS WITH UNCONTROLLED ASTHMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Saleh, C.
    Kim, L.
    Whalen-Browne, A.
    Chu, D.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S37 - S38
  • [10] Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile
    Rogliani, Paola
    Cavalli, Francesco
    Chetta, Alfredo
    Cazzola, Mario
    Calzetta, Luigino
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 565 - 577
1234